RVPH Live signaler | Maksimer profitt med Getagraph.com

KJøP 117174 min ago

@ $4.65

Utstedt: 13 feb 2024 @ 18:23

Avkastning: -31.18%

Forrige signal: feb 13 - 15:32

Forrige signal: Selg

Avkastning: 4.26 %

Live Chart Being Loaded With Signals

Commentary (3 mai 2024 @ 22:00):

Stats
Dagens volum	109 244
Gjennomsnittsvolum	260 104
Markedsverdi	89.34M
EPS	$0 ( 2024-04-04 )
Neste inntjeningsdato	( $-0.280 ) 2024-05-20
Last Dividend	$0 ( N/A )
Next Dividend	$0 ( N/A )
P/E	-1.940
ATR14	$0.0110 (0.34%)

Insider Trading

Date	Person	Action	Amount	type
2023-11-20	Saxena Parag	Buy	585 366	Pre-Funded Warrant
2023-11-20	Saxena Parag	Buy	585 366	Common Stock Warrant (right to buy)
2023-11-13	Funtleyder Leslie D.	Buy	8 200	Stock Option (right to buy)
2023-11-13	Patel Purav	Buy	8 200	Stock Option (right to buy)
2023-11-13	Saxena Parag	Buy	8 200	Stock Option (right to buy)

INSIDER POWER
100.00
Last 72 transactions
Buy: 9 383 157 \| Sell: 2 515 186

Volum Korrelasjon

Lang: 0.03 (neutral)

Kort: 0.86 (strong)

Signal:(67.734) Same movement expected

Reviva Pharmaceuticals Korrelasjon

10 Mest positive korrelasjoner
RUN	0.875
LAZR	0.854
CLLS	0.849
MAXN	0.841
MLTX	0.835
AFRM	0.834
MDGS	0.833
DLTH	0.833
FCEL	0.832
RDUS	0.829

10 Mest negative korrelasjoner
ISNS	-0.839
APOP	-0.832

Visste du det?

Korrelasjon er en statistisk måling som beskriver forholdet mellom to variabler. Den varierer fra -1 til 1, hvor -1 indikerer en perfekt negativ korrelasjon (hvor en variabel øker, går den andre ned), 1 indikerer en perfekt positiv korrelasjon (hvor en variabel øker, går den andre også opp), og 0 indikerer ingen korrelasjon (det er ingen forhold mellom variablene).

Korrelasjon kan brukes til å analysere forholdet mellom to variabler, ikke bare aksjer. Det er vanligvis brukt innen områder som finans, økonomi, psykologi, og mer.

Reviva Pharmaceuticals Korrelasjon - Valuta/Råvare

-0.41
( neutral )

-0.22
( neutral )

0.00
( neutral )

-0.48
( neutral )

0.58
( weak )

0.61
( weak )

Reviva Pharmaceuticals Økonomi

Annual	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.250

FY	2022
Omsetning:	$0
Bruttogevinst:	$0 (0.00 %)
EPS:	$-1.250

FY	2021
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-0.662

FY	2020
Omsetning:	$0.00
Bruttogevinst:	$0.00 (0.00 %)
EPS:	$-1.240

Financial Reports:

No articles found.

Reviva Pharmaceuticals

Reviva Pharmaceuticals Holdings, Inc., a clinical-stage biopharmaceutical company, discovers, develops, and commercializes next-generation therapeutics for diseases targeting unmet medical needs in the areas of central nervous system, respiratory, cardiovascular, metabolic, and inflammatory diseases. The company's lead product candidate is RP5063, which is in Phase III clinical trials for the treatment of schizophrenia, as well as completed Phase I clinical trials to treat bipolar disorder, major depressive disorder, attentiondeficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease, Parkinson's disease psychosis, attention deficit hyperactivity disorder, pulmonary arterial hypertension, and idiopathic pulmonary fibrosis. It is also developing RP1208 that is in pre-clinical development studies for the treatment of depression and obesity. The company is headquartered in Cupertino, California.